Our results indicate the potential of usefulness of CCL20 level as a biomarker to differentiate endometriosis in the setting of ovarian tumors with elevated CA125 levels, which can reduce the false positivity rate from 41.11% in preoperative diagnosis to 15.56% at the optimal cutoff value of CCL20. This evidence concerns the gene MUC16 and ovarian neoplasm.